Cargando…
Bioactive Secondary Metabolites from a New Terrestrial Streptomyces sp. TN262
During our search for Streptomyces spp. as new producers of bioactive secondary metabolites, the ethyl acetate extract of the new terrestrial Streptomyces isolate TN262 delivered eight antimicrobially active compounds. They were identified as 1-acetyl-β-carboline (1), tryptophol (2), cineromycin B (...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Humana Press Inc
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3128704/ https://www.ncbi.nlm.nih.gov/pubmed/19842066 http://dx.doi.org/10.1007/s12010-009-8808-4 |
_version_ | 1782207464147517440 |
---|---|
author | Elleuch, Lobna Shaaban, Mohamed Smaoui, Slim Mellouli, Lotfi Karray-Rebai, Ines Fourati-Ben Fguira, Lilia Shaaban, Khaled A. Laatsch, Hartmut |
author_facet | Elleuch, Lobna Shaaban, Mohamed Smaoui, Slim Mellouli, Lotfi Karray-Rebai, Ines Fourati-Ben Fguira, Lilia Shaaban, Khaled A. Laatsch, Hartmut |
author_sort | Elleuch, Lobna |
collection | PubMed |
description | During our search for Streptomyces spp. as new producers of bioactive secondary metabolites, the ethyl acetate extract of the new terrestrial Streptomyces isolate TN262 delivered eight antimicrobially active compounds. They were identified as 1-acetyl-β-carboline (1), tryptophol (2), cineromycin B (3), 2,3-dihydrocineromycin B (4), cyclo-(tyrosylprolyl) (5), 3-(hydroxyacetyl)-indole (6), brevianamide F (7), and cis-cyclo-(l-prolyl-l-leucyl) (8). Three further metabolites were detected in the unpolar fractions using GC–MS and tentatively assigned as benzophenone (9), N-butyl-benzenesulfonamide (10), and hexanedioic acid-bis-(2-ethylhexyl) ester (11). This last compound is known as plasticizer derivatives, but it has never been described from natural sources. In this article, we describe the identification of the new Streptomyces sp. isolate TN262 using its cultural characteristics, the nucleotide sequence of the corresponding 16S rRNA gene and the phylogenetic analysis, followed by optimization, large-scale fermentation, isolation of the bioactive constituents, and determination of their structures. The biological activity of compounds (2), (3), (4), and those of the unpolar fractions was addressed as well. |
format | Online Article Text |
id | pubmed-3128704 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Humana Press Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-31287042011-08-10 Bioactive Secondary Metabolites from a New Terrestrial Streptomyces sp. TN262 Elleuch, Lobna Shaaban, Mohamed Smaoui, Slim Mellouli, Lotfi Karray-Rebai, Ines Fourati-Ben Fguira, Lilia Shaaban, Khaled A. Laatsch, Hartmut Appl Biochem Biotechnol Article During our search for Streptomyces spp. as new producers of bioactive secondary metabolites, the ethyl acetate extract of the new terrestrial Streptomyces isolate TN262 delivered eight antimicrobially active compounds. They were identified as 1-acetyl-β-carboline (1), tryptophol (2), cineromycin B (3), 2,3-dihydrocineromycin B (4), cyclo-(tyrosylprolyl) (5), 3-(hydroxyacetyl)-indole (6), brevianamide F (7), and cis-cyclo-(l-prolyl-l-leucyl) (8). Three further metabolites were detected in the unpolar fractions using GC–MS and tentatively assigned as benzophenone (9), N-butyl-benzenesulfonamide (10), and hexanedioic acid-bis-(2-ethylhexyl) ester (11). This last compound is known as plasticizer derivatives, but it has never been described from natural sources. In this article, we describe the identification of the new Streptomyces sp. isolate TN262 using its cultural characteristics, the nucleotide sequence of the corresponding 16S rRNA gene and the phylogenetic analysis, followed by optimization, large-scale fermentation, isolation of the bioactive constituents, and determination of their structures. The biological activity of compounds (2), (3), (4), and those of the unpolar fractions was addressed as well. Humana Press Inc 2009-10-20 2010-09 /pmc/articles/PMC3128704/ /pubmed/19842066 http://dx.doi.org/10.1007/s12010-009-8808-4 Text en © Humana Press 2009 |
spellingShingle | Article Elleuch, Lobna Shaaban, Mohamed Smaoui, Slim Mellouli, Lotfi Karray-Rebai, Ines Fourati-Ben Fguira, Lilia Shaaban, Khaled A. Laatsch, Hartmut Bioactive Secondary Metabolites from a New Terrestrial Streptomyces sp. TN262 |
title | Bioactive Secondary Metabolites from a New Terrestrial Streptomyces sp. TN262 |
title_full | Bioactive Secondary Metabolites from a New Terrestrial Streptomyces sp. TN262 |
title_fullStr | Bioactive Secondary Metabolites from a New Terrestrial Streptomyces sp. TN262 |
title_full_unstemmed | Bioactive Secondary Metabolites from a New Terrestrial Streptomyces sp. TN262 |
title_short | Bioactive Secondary Metabolites from a New Terrestrial Streptomyces sp. TN262 |
title_sort | bioactive secondary metabolites from a new terrestrial streptomyces sp. tn262 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3128704/ https://www.ncbi.nlm.nih.gov/pubmed/19842066 http://dx.doi.org/10.1007/s12010-009-8808-4 |
work_keys_str_mv | AT elleuchlobna bioactivesecondarymetabolitesfromanewterrestrialstreptomycessptn262 AT shaabanmohamed bioactivesecondarymetabolitesfromanewterrestrialstreptomycessptn262 AT smaouislim bioactivesecondarymetabolitesfromanewterrestrialstreptomycessptn262 AT melloulilotfi bioactivesecondarymetabolitesfromanewterrestrialstreptomycessptn262 AT karrayrebaiines bioactivesecondarymetabolitesfromanewterrestrialstreptomycessptn262 AT fouratibenfguiralilia bioactivesecondarymetabolitesfromanewterrestrialstreptomycessptn262 AT shaabankhaleda bioactivesecondarymetabolitesfromanewterrestrialstreptomycessptn262 AT laatschhartmut bioactivesecondarymetabolitesfromanewterrestrialstreptomycessptn262 |